All VA diagnostic codes › §4.119
38 CFR Diagnostic Code 7919 — C-cell hyperplasia of the thyroid
Rating schedule §4.119 — § 4.119 Schedule of ratings—endocrine system.
The rating schedule prints no percentage table under Diagnostic Code 7919. Its text for this code reads:
Official 2026 VA monthly compensation, including the 2.8% COLA increase.
Dependent add-ons start at a 30% rating. Child-only and dependent-parent rates: see the full 2026 pay chart.
2026 base rates, all ratings (veteran alone)
| Rating | Monthly (2026, incl. 2.8% COLA) |
|---|---|
| 10% | $180.42 |
| 20% | $356.66 |
| 30% | $552.47 |
| 40% | $795.84 |
| 50% | $1,132.90 |
| 60% | $1,435.02 |
| 70% | $1,808.45 |
| 80% | $2,102.15 |
| 90% | $2,362.30 |
| 100% | $3,938.58 |
If antineoplastic therapy is required, evaluate as a malignant neoplasm under DC 7914. If a prophylactic thyroidectomy is performed (based upon genetic testing) and antineoplastic therapy is not required, evaluate as hypothyroidism under DC 7903.
Amendment history. eCFR records changes to the section holding this code on the dates below, with the differing passage within a few lines of code 7919. The criteria in force on a claim’s filing or decision date can govern it.
- 2017-12-10 — §4.119 amended near code 7919 (text as amended)
Source. Quoted from 38 CFR Part 4, the VA Schedule for Rating Disabilities, as published by the eCFR for 2026-07-01. We quote the regulation rather than paraphrase it. The rating schedule changes; check the eCFR link for the current text.
This is reference information, not a rating decision and not legal advice. What a claim actually receives depends on the evidence of record.
Does your rating decision hold up under a real audit?
Upload your decision letter and C&P exams — VetAid's analyzer reads the full file, checks every examiner statement word-for-word against your records, and shows which arguments for a higher rating actually hold. Free, and we never take a cut of your back pay.
Analyze my claim free →